ABSTRACT
Ocular parasitic infections, which lead to significant morbidity and mortality in particular areas, have been shifting from endemic areas to other regions due to tourism, wars and migrations in recent years. This study aimed to review the parasitic factors related to the human eye and their geographical distribution, pathogenesis of the disease and the methods used in and studies conducted for its diagnosis. PubMed, MEDLINE and Google databases were researched and reviewed for relevant keywords in recent publications. Although such parasitic infections are rare in many parts of the world, they continue to be an important public health problem that affects human and animal health in places with poor health conditions. The distribution of ocular parasites and their spread to non-endemic areas are facilitated. The morbidity and mortality risks have been increasing due to the difficulties encountered by health personnel in the diagnosis of these parasitic infections. Defining them accurately and appropriately can save not only eyesight but also lives.
Keywords: Eye parasites, retinitis, endophthalmitis, conjunctivitis, uveitis, blepharitis, tropical parasites, zoonotic parasites, ocular protozoa, ocular helminths, ocular arthropods, travel and infection
References
1
Nimir AR, Saliem A, Ibrahim IA. Ophthalmic parasitosis: a review article. Interdiscip Perspect Infect Dis 2012; 2012: 587402.
2
Malla N, Goyal K. Ocular Parasitic Infections - An Overview. Advances in Common Eye Infections. 2016. doi: 10.5772/64137
3
Padhi TR, Das S, Sharma S, Rath S, Rath S, Tripathy D, et al. Ocular parasitoses: A comprehensive review. Surv Ophthalmol 2017; 62: 161-89.
4
Das D, Islam S, Bhattacharjee H, Deka A, Yambem D, Tahiliani PS, et al. Parasitic diseases of zoonotic importance in humans of northeast India, with special reference to ocular involvement. Eye Brain 2014; 6: 1-8.
5
Das D, Ramachandra V, Islam S, Bhattacharjee H, Biswas J, Koul A, et al. Update on pathology of ocular parasitic disease. Indian J Ophthalmol 2016; 64: 794-802.
6
Otranto D, Eberhard ML. Zoonotic helminths affecting the human eye. Parasit Vectors 2011; 4: 41.
7
Hoti SL, Tandon V. Ocular parasitoses and their immunology. Ocul Immunol Inflamm 2011; 19: 385-96.
8
Izadi M, Pourazizi M, Babaei M, Saffaei A, Alemzadeh-Ansari MH. Ocular Parasitosis Caused by Protozoan Infection during Travel: Focus on Prevention and Treatment. Int J Prev Med 2018;9:79.
9
Sharma S. Diagnosis of infectious diseases of the eye. Eye (Lond) 2012; 26: 177-84.
10
Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and Parasitic Infections of the Eye. Clin Microbiol Rev 2000; 13: 662-85.
11
Rathinam SR, Annamalai R, Biswas J. Intraocular parasitic infections. Ocul Immunol Inflamm 2011; 19: 327-36.
12
World Health Organization (WHO). Crossing the billion. Preventive chemotherapy for neglected tropical diseases. Lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases and trachoma 2017.
13
Hosseini SA, Amouei A, Sharif M, Sarvi S, Galal L, Javidnia J, et al. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples. Epidemiol Infect 2018; 147: 1-9.
14
Aleixo ALQDC, Vasconcelos C de Oliveira R, Cavalcanti Albuquerque M, Biancardi AL, Land Curi AL, Israel Benchimol E, et al. Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-γ +874 T/A as risk factors for recurrence in a survival analysis. PLoS One 2019; 14: e0211627.
15
Khan K, Khan W. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitol Int 2018; 67: 715-21.
16
Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res 2017; 57: 1-12.
17
Belk K, Connolly MP, Schlesinger L, Ben-Harari RR. Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017. Pathog Glob Health 2018; 112: 428-37.
18
Arshadi M, Akhlaghi L, Meamar AR, Alizadeh Ghavidel L, Nasiri K, Mahami-Oskouei M, et al. Sero-molecular detection, multi-locus genotyping, and clinical manifestations of ocular toxoplasmosis in patients in northwest Iran. Trans R Soc Trop Med Hyg 2019; 113: 195-202.
19
Casoy J, Nascimento H, Silva LMP, Fernández-Zamora Y, Muccioli C, Dias JRO, et al. Effectiveness of Treatments for Ocular Toxoplasmosis. Ocul Immunol Inflamm 2020; 28: 249-55.
20
Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Piñero JE, Valladares B. Acanthamoeba keratitis: An emerging disease gathering importance worldwide? Trends Parasitol 2013; 29: 181-7.
21
Rahimi F, Rafizadeh SM, Beheshtnejad AH, Hashemian MN, Zare MA, Siatiri H, et al. Acanthamoeba keratitis and its associated risk factors in Farabi eye hospital of Tehran. Iran J Ophthalmol 2013; 25: 297-303.
22
Jiang C, Sun X, Wang Z, Zhang Y. Acanthamoeba keratitis: Clinical characteristics and management. Ocul Surf 2015; 13: 164-8.
23
Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: Diagnosis, treatment, and outcomes. Cornea 2016; 35: 713-20.
24
Muiño L, Rodrigo D, Villegas R, Romero P, Peredo DE, Vargas RA, et al. Effectiveness of sampling methods employed for Acanthamoeba keratitis diagnosis by culture. Int Ophthalmol 2018; 39: 1451-8.
25
Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers’ diarrhea: Systematic review from 1973 to the present. Am J Trop Med Hyg 2009; 80: 609-14.
26
Takaoka K, Gourtsoyannis Y, Hart JD, Armstrong M, Daniel A, Mewse E, et al. Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. J Travel Med 2016; 23.
27
Halliez MC, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013; 19: 8974-85.
28
Turnbull AM, Lin Z, Matthews BN. Severe bilateral anterior uveitis secondary to giardiasis, initially misdiagnosed as a side effect of metronidazole. Eye (Lond) 2013; 27: 1225-6.
29
Mansueto P, Seidita A, Vitale G, Cascio A. Leishmaniasis in travelers: A literature review. Travel Med Infect Dis 2014; 12: 563-81.
30
Maude RJ, Ahmed BU, Rahman AH, Rahman R, Majumder MI, Menezes DB, et al. Retinal changes in visceral leishmaniasis by retinal photography. BMC Infect Dis 2014; 14.
31
Sharifi I, Aflatoonian MR, Fekri AR, Hakimi Parizi M, Aghaei Afshar A, Khosravi A, et al. A comprehensive review of cutaneous leishmaniasis in kerman province, Southeastern Iran-narrative review article. Iran J Public Health 2015; 44: 299-307.
32
Mohammadpour I, Motazedian MH, Handjani F, Hatam GR. Cutaneous Leishmaniasis of the Eyelids: A Case Series with Molecular Identification and Literature Review. Korean J Parasitol 2016; 54: 787-92.
33
Caminade C, Kovats S, Rocklov J, Tompkins AM, Morse AP, Colón-González FJ, et al. Impact of climate change on global malaria distribution. Proc Natl Acad Sci USA 2014; 111: 3286-91.
34
Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med 2013; 158: 456-68.
35
Barrera V, Hiscott PS, Craig AG, White VA, Milner DA, Beare NA, et al. Severity of retinopathy parallels the degree of parasite sequestration in the eyes and brains of Malawian children with fatal cerebral malaria. J Infect Dis 2015; 211: 1977-86.
36
Singh J, Verma R, Tiwari A, Mishra D, Singh HP. Retinopathy as a prognostic marker in cerebral malaria. Indian Pediatr 2016; 53: 315-7.
37
Paquet-Durand F, Beck SC, Das S, Huber G, Le Chang, Schubert T, et al. A retinal model of cerebral malaria. Sci Rep 2019; 9: 3470.
38
Warrasak S, Euswas A, Fukuda MM, Ittiverakul M, Miller RS, Krudsood S, et al. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure. Int Ophthalmol 2019; 39: 1767-82.
39
Fröhlich SJ, Miño de Kaspar H, Perán R, Rojas de Arias A, Sanchez Insfran N, Moreno Azorero R, et al. [Eye involvement in Chagas disease (American trypanosomiasis). 1996/1997 studies in Paraguay]. Ophthalmologe 1998; 95: 168-71.
40
Vargas D, Castro C. Pupillometry in Chagas disease. Arq Bras Oftalmol 2018; 81: 195-201.
41
Conrady CD, Hanson KE, Mehra S, Carey A, Larochelle M, Shakoor A. The First Case of Trypanosoma cruzi-Associated Retinitis in an Immunocompromised Host Diagnosed With Pan-Organism Polymerase Chain Reaction. Clin Infect Dis 2018; 67: 141-3.
42
Herrera L, Martínez C, Carrasco H, Jansen AM, Urdaneta-Morales S. Cornea as a tissue reservoir of Trypanosoma cruzi. Parasitol Res 2007; 100: 1395-9.
43
Joseph J, Vemuganti GK, Sharma S. Microsporidia: emerging ocular pathogens. Indian J Med Microbiol 2005; 23: 80-91.
44
Taju S, Tilahun Y, Ayalew M, Fikrie N, Schneider J, Kempen JH. Diagnosis and treatment of microsporidial keratoconjunctivitis: literature review and case series. J Ophthalmic Inflamm Infect 2011; 1: 105-10.
45
Leroy J, Cornu M, Deleplancque AS, Bart A, Loridant S, Fréalle E, et al. Case Report: Ocular Microsporidiosis: Case in a Patient Returning from India and Review of the Literature. Am J Trop Med Hyg 2018; 99: 90-3.
46
Heyworth MF. Molecular diagnosis of human microsporidian infections. Trans R Soc Trop Med Hyg 2017; 111: 382-3.
47
Cortez RT, Ramirez G, Collet L, Giuliari GP. Ocular parasitic diseases: a review on toxocariasis and diffuse unilateral subacute neuroretinitis. J Pediatr Ophthalmol Strabismus 2011; 48: 204-12.
48
Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol 2010; 104: 3-23.
49
Fonseca C, Silva AM, Freire S, Proença R. Ocular toxocariasis: atypical clinical course. BMJ Case Rep 2019; 12: e228717.
50
Choi KD, Choi JH, Choi SY, Jung JH. Toxocara optic neuropathy: clinical features and ocular findings. Int J Ophthalmol 2018; 11: 520-3. [eCollection 2018]
51
Yoon SY, Baek S, Park SY, Shin B, Kwon HS, Cho YS, et al. Clinical course and treatment outcomes of toxocariasis-related eosinophilic disorder. Medicine (Baltimore) 2018; 97: e12361.
52
Centers for Disease Control and Prevention [CDC]. Baylisascariasis [online]. Available from: URL: https://www.cdc.gov/dpdx/baylisascariasis/index.html (Accessed Dec 4, 2013).
53
Peters JM, Madhavan VL, Kazacos KR, Husson RN, Dangoudoubiyam S, Soul JS. Good outcome with early empiric treatment of neural larva migrans due to Baylisascaris procyonis. Pediatrics 2012; 129: e806-11.
54
Bhattacharjee H, Das D, Medhi J. Intravitreal gnathostomiasis and review of literature. Retina 2007; 27: 67-73.
55
Nawa Y, Yoshikawa M, Sawanyawisuth K, Chotmongkol V, Figueiras SF, Benavides M, et al. Ocular Gnathostomiasis-Update of Earlier Survey. Am J Trop Med Hyg 2017; 97: 1232-4.
56
Chandy A, Thakur AS, Singh MP, Manigauha A. A review of neglected tropical diseases: filariasis. Asian Pac J Trop Med 2011; 4: 581-6.
57
Olliaro PL, Kuesel AC, Halleux CM, Sullivan M, Reeder JC. Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. PLoS Negl Trop Dis 2018; 12: e0006837.
58
Nicholls RS, Duque S, Olaya LA, López MC, Sánchez SB, Morales AL, et al. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world. Parasit Vectors 2018; 11.
59
Colebunders R, Basáñez MG, Siling K, Post RJ, Rotsaert A, Mmbando B, et al. From river blindness control to elimination: bridge over troubled water. Infect Dis Poverty 2018; 7: 21.
60
Komlan K, Vossberg PS, Gantin RG, Solim T, Korbmacher F, Banla M, et al. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin. PLoS Negl Trop Dis 2018; 12: e0006312. [eCollection 2018 Mar]
61
Mirahmadi H, Maleki A, Hasanzadeh R, Ahoo MB, Mobedi I, Rostami A. Ocular dirofilariasis by Dirofilaria immitis in a child in Iran: A case report and review of the literature. Parasitol Int 2017; 66: 978-81.
62
Mani A, Khan MA, Kumar VP. Subcutaneous dirofilariasis of the eyelid. Med J Armed Forces India 2019; 75: 112-4.
63
Montesel A, Bendinelli A, Figus M, Posarelli C. There is a worm in my eye! Ocular dirofilariasis. Eur J Ophthalmol 2019; 29: NP5-8. Showler AJ, Kubofcik J, Ricciardi A, Nutman TB. Differences in the Clinical and Laboratory Features of Imported Onchocerciasis in Endemic Individuals and Temporary Residents. Am J Trop Med Hyg 2019; 100: 1216-22.
64
Okonkwo ON, Hassan AO, Alarape T, Akanbi T, Oderinlo O, Akinye A, et al. Removal of adult subconjunctival Loa loa amongst urban dwellers in Nigeria. PLoS Negl Trop Dis 2018; 12: e0006920.
65
Akue JP, Eyang-Assengone ER, Dieki R. Loa loa infection detection using biomarkers: current perspectives. Res Rep Trop Med 2018; 9: 43-8. [eCollection 2018]
66
Diao Z, Wang J, Qi H, Li X, Zheng X, Yin C. Human ocular angiostrongyliasis: a literature review. Trop Doct 2011; 41: 76-8.
67
Tiwari US, Aishwarya A, Gandhi S, Sisodia P. Angiostrongylus cantonensis in anterior chamber. Indian J Ophthalmol 2019; 67: 158-60.
68
Sawanyawisuth K, Chindaprasirt J, Senthong V, Limpawattana P, Auvichayapat N, Tassniyom S, et al. Clinical manifestations of Eosinophilic meningitis due to infection with Angiostrongylus cantonensis in children. Korean J Parasitol 2013; 51: 735-8. [Epub 2013 Dec 31]
69
Sah R, Khadka S, Adhikari M, Niraula R, Shah A, Khatri A, et al. Human Thelaziasis: Emerging Ocular Pathogen in Nepal. Open Forum Infect Dis 2018; 5: ofy237.
70
Chowdhury R, Gogoi M, Sarma A, Sharma A. Ocular thelaziasis: A case report from Assam, India. Trop Parasitol 2018; 8: 94-7. [eCollection 2018 Oct]
71
Kocięcki J, Czaplicka E, Kocięcka W. Ocular system involvement in the course of human trichinellosis. Pathological and diagnostic aspects. Acta Parasitol 2014; 59: 493-501.
72
Li JJ, Zhang LW, Li H, Hu ZL. Clinical and pathological characteristics of intraocular cysticercosis. Korean J Parasitol 2013; 51: 223-9.
73
Ganesh SK, Priyanka. Analysis of Clinical Profile, Investigation, and Management of Ocular Cysticercosis Seen at a Tertiary Referral Centre. Ocul Immunol Inflamm 2018; 26: 550-7.
74
Sanli M, Sabuncuoğlu H, Keskin T. Primary intraorbital hydatid cyst: an unusual location, case report and review of the literature. Minim Invasive Neurosurg 2007; 50: 367-9.
75
Kim JG, Ahn CS, Sohn WM, Nawa Y, Kong Y. Human Sparganosis in Korea. J Korean Med Sci 2018; 33: e273.
76
Arya LK, Rathinam SR, Lalitha P, Kim UR, Ghatani S, Tandon V. Trematode Fluke Procerovum varium as Cause of Ocular Inflammation in Children, South India. Emerg Infect Dis 2016; 22: 192-200.
77
Chunge CN, Chunge RN, Masinde MS, Atinga JN. An outbreak of acute schistosomiasis following a church retreat to Mwanza, Tanzania,2008. J Travel Med 2011; 18: 408-10.
78
Panadero-Fontán R, Otranto D. Arthropods affecting the human eye. Vet Parasitol 2015; 208: 84-93.
79
Gupta PC, Ram J, Faisal TT, Agarwal A, Khurana S, Prasad A. Ocular Myiasis. J Ophthalmic Vis Res 2018; 13: 361-2.
80
Centers for Disease Control and Prevention. DPDx - Laboratory Identification of Parasites of Public Health Concern. Pthiriasis. Available from: URL: https://www.cdc.gov/dpdx/pthiriasis/index.html (Accessed March 11, 2020)
81
Özyol P, Özyol E, Sankur F. External ophthalmomyiasis: a case series and review of ophthalmomyiasis in Turkey. Int Ophthalmol 2016; 36: 887-91.
82
Zeytun E, Karakurt Y. Prevalence and Load of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in Patients With Chronic Blepharitis in the Province of Erzincan, Turkey. J Med Entomol 2019; 56: 2-9.
